Pre-operative proton pump inhibitor use is associated with increased post-operative complications following anatomic total shoulder arthroplasty
Authors:
- Muhammad Hamza IlyasMIMuhammad Hamza Ilyas
- Joseph A. AbboudJAJoseph A. Abboud
- Hafiz F. KassamHKHafiz F. Kassam
Open Access
- 29 September 2026
- journal article
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10 (4)
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Gastrointestinal Bleeds Are a Rare Event After Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2025
- Routine Prescription of Proton Pump Inhibitors in the Perioperative Period is Associated With Decreased Rates of 2-Year Revision Surgery After Total Hip and Knee ArthroplastyThe Journal of Arthroplasty, 2024
- Risk of Gastrointestinal Bleeding With Extended Use of Nonsteroidal Anti-Inflammatory Drug Analgesia After Joint ArthroplastyThe Journal of Arthroplasty, 2021
- Inappropriateness of Proton Pump Inhibitors After Hospital Discharge Is Associated with Thirty-Day Hospital ReadmissionDigestive Diseases and Sciences, 2021
- Proton-pump inhibitors elevate infection rate in cardiothoracic surgery patients by influencing PMN function in vitro and in vivoJournal of Leukocyte Biology, 2018
- Yearly Trends in Elective Shoulder Arthroplasty, 2005–2013Arthritis Care & Research, 2017
- Prevention of Periprosthetic Joint InfectionThe Journal of Arthroplasty, 2015
- Prevalence of Modifiable Surgical Site Infection Risk Factors in Hip and Knee Joint Arthroplasty Patients at an Urban Academic HospitalThe Journal of Arthroplasty, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Inhibition of lysosomal enzyme activities by proton pump inhibitorsJournal of Gastroenterology, 2013